The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

Out of six evaluable patients on that dose, four achieved remission and stable kidney function. A higher 240 mg dose achieved similar results. Vertex’s move for Alpine marks a turnaround in the ...

Navina, a clinical intelligence company, closed a $55 million Series C funding round. The round was led by a division of ...

A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis ... or one F508del copy and one of 14 other so-called “minimal function” mutations in CFTR. The new EU approval ...

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...

Three Florida Tech students are making a mechanical 'spy' manatee to covertly learn sea cows' deepest secrets.

We are the Artful Dodgers of the globalised world, experts at ducking and diving - but even the Dodger gets caught in the end ...

By investing in adaptable e-invoicing solutions, companies can position themselves for success in an evolving regulatory ...

Endiya actively assists portfolio companies with product rollouts, customer acquisition hiring, and preparing for future ...